glp-1 for ckd receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease Glucagon-like Peptide Receptor Agonists and
Description
Extended-release formulations may be considered to improve tolerability and compliance in those who have difficulty adhering to a twice-daily immediate-release regimen
Metformin is commonly used as a first-line treatment for PCOS
Track each injection
Psychiatric adverse events associated with GLP-1 receptor agonists: a real-world pharmacovigilance study based on the FDA adverse event reporting system database
Hiroto Kobayashi, Yamagata University, Japan Updates Copyright 2022 Vigil, Melndez, Petkovic and Del Ro
10.1074/jbc.M110.150821 J
